The first digital tablets are getting ready to enter the market
Last reviewed: 16.10.2021
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
Swallowed microchips, included in the composition of tablets and pills, tell a lot about your doctor. In particular, they will tell you about how accurately and regularly you follow the doctor's advice about the frequency of admission and the dose of recommended drugs.
The first sensors of this kind have already received approval from the US supervisory authorities and are preparing to enter the market. Attention, friends: the era of digital medicine is coming.
Doctors sincerely see in such devices the solution of the problem, because, according to them, at least half of the patients take medication completely differently than prescribed. At least they can now know in time when to remind the patient of strict compliance with the prescription, or quickly understand why the proposed treatment does not work. The creation and production of original devices is handled by Proteus Digital Health, one of the residents of the Silicon Valley. To her credit, it should be noted that the company understands that such devices are most reminiscent of the imminent offensive of "1984", when Big Brother will observe even how you swallow the pills.
A sensor the size of a large grain of sand is a miniature silicon chip containing trace amounts of magnesium and copper. If swallowed, the chip generates a small amount of tension in response to the effects of gastric juice, which transmits the signal to the skin of the patient, where a specially attached sticker (similar to a smoking patch) redirects information to a mobile phone belonging to the doctor (or hospital, but not to the patient).
The main candidates for rapid introduction are drugs taken by chronic patients and age patients. In the first case, inattention can cause a sharp progression of the disease, and in the second case the patient may simply not remember what and how it takes. Thus, the manufacturer emphasizes, the main idea of the chips is not in punishing the careless patient, but in helping both patients and doctors (the latter will be able to more thoroughly monitor how the patient responds to treatment).